Article ; Online: Assessment of thirty-day readmission rate, timing, causes and predictors after hospitalization with COVID-19.
2021 Volume 290, Issue 1, Page(s) 157–165
Abstract: ... predictors and outcomes of 30-day readmission after COVID-19 hospitalization.: Methods: From 13 March to 9 ... hospitalization with coronavirus disease 2019 (COVID-19).: Objectives: To examine the rate, timing, causes ... Conclusion: With 4.5% of the thirty-day readmission rate, COVID-19 survivors were readmitted early after ...
| Abstract | Background: There are limited data on the characteristics of 30-day readmission after hospitalization with coronavirus disease 2019 (COVID-19). Objectives: To examine the rate, timing, causes, predictors and outcomes of 30-day readmission after COVID-19 hospitalization. Methods: From 13 March to 9 April 2020, all patients hospitalized with COVID-19 and discharged alive were included in this retrospective observational study. Multivariable logistic regression was used to identify the predictors of 30-day readmission, and a restricted cubic spline function was utilized to assess the linearity of the association between continuous predictors and 30-day readmission. Results: A total of 1062 patients were included in the analysis, with a median follow-up time of 62 days. The mean age of patients was 56.5 years, and 40.5% were women. At the end of the study, a total of 48 (4.5%) patients were readmitted within 30 days of discharge, and a median time to readmission was 5 days. The most common primary diagnosis of 30-day readmission was a hypoxic respiratory failure (68.8%) followed by thromboembolism (12.5%) and sepsis (6.3%). The patients with a peak serum creatinine level of ≥1.29 mg/dL during the index hospitalization, compared to those with a creatinine of <1.29 mg/dL, had 2.4 times increased risk of 30-day readmission (adjusted odds ratio: 2.41; 95% CI: 1.23-4.74). The mortality rate during the readmission was 22.9%. Conclusion: With 4.5% of the thirty-day readmission rate, COVID-19 survivors were readmitted early after hospital discharge, mainly due to morbidities of COVID-19. One in five readmitted COVID-19 survivors died during their readmission. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | COVID-19/therapy ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Pandemics ; Patient Readmission/statistics & numerical data ; Pneumonia, Viral/therapy ; Pneumonia, Viral/virology ; Prognosis ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 ; Time Factors | |||||
| Language | English | |||||
| Publishing date | 2021-02-05 | |||||
| Publishing country | England | |||||
| Document type | Journal Article ; Observational Study | |||||
| ZDB-ID | 96274-0 | |||||
| ISSN | 1365-2796 ; 0954-6820 | |||||
| ISSN (online) | 1365-2796 | |||||
| ISSN | 0954-6820 | |||||
| DOI | 10.1111/joim.13241 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Ua VI Zs.44: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.